Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky
Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction. This narrative review provides an informed perspective on the importance of ur...
Gespeichert in:
Veröffentlicht in: | Pain physician 2010-03, Vol.13 (2), p.167-186 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 186 |
---|---|
container_issue | 2 |
container_start_page | 167 |
container_title | Pain physician |
container_volume | 13 |
creator | Gilbert, John W Wheeler, G R Mick, G E Storey, B B Herder, S L Richardson, G B Watts, E Gyarteng-Dakwa, K Marino, B S Kenney, C M Siddiqi, M Broughton, P G |
description | Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction.
This narrative review provides an informed perspective on the importance of urine drug testing in the medical treatment of chronic noncancer pain. The history and current uses of urine drug tests in the United States are reviewed, the prevalence and nature of prescription drug misuse is described as is related to chronic noncancer pain, and implications and considerations for practitioners are presented related to the noncancer pain diagnosis and treatment.
Practitioners are confronted with the ethical and legal dilemma of being called to adequately treat chronic pain in a culture with a high prevalence of prescription drug abuse. Yet the symptoms of drug abuse are nonspecific and therefore of limited value to the practitioner in determining patient compliance to drug treatment regimens. In contrast, urine drug testing has a reliable history, both in and out of medicine, as an independent sign of drug misuse. This sign can be used to aid in the diagnosis and treatment of drug misuse and underlying addictions to improve patient outcomes.
Regular urine drug testing should be a part of acute and chronic pain management whether or not the patient has any signs or symptoms of drug misuse. |
doi_str_mv | 10.36076/ppj.2010/13/167 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733563619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733563619</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-d4bc92671a2fa58dda2e4357be180eaa9ef14fe7f752ea5ad84956e8fb19668d3</originalsourceid><addsrcrecordid>eNpdkb1uHCEURpEVK9446V1FSClSjRe4AzOki6z8WLKUJqkRy9xZs96BCTDFPoFf20zspEiFxD3fJ7iHkCvOrkGxTm3n-XAtGGdbDluuujOyEVyyhvNWvyIbLgEa4FJfkDc5HxgDpTW8JheCAdPQw4Y83k5zTMUGhzSOdEk-IB3SsqcFc_FhT32g5R5pSWjLhKGsmLtPMXhHQwxujSY6Wx8-UT_NR-9s8THklUvo1sSEQ71NSOdYx6cat2GPea1-qPPFPZzekvPRHjO-ezkvya-vX37efG_ufny7vfl81zgQvDRDu3NaqI5bMVrZD4MV2ILsdsh7htZqHHk7Yjd2UqCVduhbLRX2445rpfoBLsnH5945xd9L_aKZfHZ4PNqAccmmA5AKFNeV_PAfeYhLCvVxRigp6yLbrq8Ue6ZcijknHM2c_GTTyXBm_jgy1ZFZHRkOpjqqkfcvxcuubuZf4K8UeAKCGI_q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2655993478</pqid></control><display><type>article</type><title>Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Gilbert, John W ; Wheeler, G R ; Mick, G E ; Storey, B B ; Herder, S L ; Richardson, G B ; Watts, E ; Gyarteng-Dakwa, K ; Marino, B S ; Kenney, C M ; Siddiqi, M ; Broughton, P G</creator><creatorcontrib>Gilbert, John W ; Wheeler, G R ; Mick, G E ; Storey, B B ; Herder, S L ; Richardson, G B ; Watts, E ; Gyarteng-Dakwa, K ; Marino, B S ; Kenney, C M ; Siddiqi, M ; Broughton, P G</creatorcontrib><description>Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction.
This narrative review provides an informed perspective on the importance of urine drug testing in the medical treatment of chronic noncancer pain. The history and current uses of urine drug tests in the United States are reviewed, the prevalence and nature of prescription drug misuse is described as is related to chronic noncancer pain, and implications and considerations for practitioners are presented related to the noncancer pain diagnosis and treatment.
Practitioners are confronted with the ethical and legal dilemma of being called to adequately treat chronic pain in a culture with a high prevalence of prescription drug abuse. Yet the symptoms of drug abuse are nonspecific and therefore of limited value to the practitioner in determining patient compliance to drug treatment regimens. In contrast, urine drug testing has a reliable history, both in and out of medicine, as an independent sign of drug misuse. This sign can be used to aid in the diagnosis and treatment of drug misuse and underlying addictions to improve patient outcomes.
Regular urine drug testing should be a part of acute and chronic pain management whether or not the patient has any signs or symptoms of drug misuse.</description><identifier>ISSN: 1533-3159</identifier><identifier>EISSN: 2150-1149</identifier><identifier>DOI: 10.36076/ppj.2010/13/167</identifier><identifier>PMID: 20309383</identifier><language>eng</language><publisher>United States: American Society of Interventional Pain Physician</publisher><subject>Drug abuse ; Drug testing ; History, 20th Century ; Humans ; Kentucky ; Legislation, Drug - trends ; Medical diagnosis ; Medicare - trends ; Opioid-Related Disorders - diagnosis ; Opioid-Related Disorders - prevention & control ; Opioid-Related Disorders - urine ; Pain ; Pain, Intractable - drug therapy ; Pain, Intractable - prevention & control ; Practice Patterns, Physicians' - legislation & jurisprudence ; Practice Patterns, Physicians' - standards ; Practice Patterns, Physicians' - trends ; Prescription drugs ; Prescriptions - standards ; Substance Abuse Detection - history ; Substance Abuse Detection - legislation & jurisprudence ; Substance Abuse Detection - standards ; Substance abuse treatment ; United States ; Urinalysis - history ; Urinalysis - standards ; Urine</subject><ispartof>Pain physician, 2010-03, Vol.13 (2), p.167-186</ispartof><rights>2010. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20309383$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gilbert, John W</creatorcontrib><creatorcontrib>Wheeler, G R</creatorcontrib><creatorcontrib>Mick, G E</creatorcontrib><creatorcontrib>Storey, B B</creatorcontrib><creatorcontrib>Herder, S L</creatorcontrib><creatorcontrib>Richardson, G B</creatorcontrib><creatorcontrib>Watts, E</creatorcontrib><creatorcontrib>Gyarteng-Dakwa, K</creatorcontrib><creatorcontrib>Marino, B S</creatorcontrib><creatorcontrib>Kenney, C M</creatorcontrib><creatorcontrib>Siddiqi, M</creatorcontrib><creatorcontrib>Broughton, P G</creatorcontrib><title>Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky</title><title>Pain physician</title><addtitle>Pain Physician</addtitle><description>Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction.
This narrative review provides an informed perspective on the importance of urine drug testing in the medical treatment of chronic noncancer pain. The history and current uses of urine drug tests in the United States are reviewed, the prevalence and nature of prescription drug misuse is described as is related to chronic noncancer pain, and implications and considerations for practitioners are presented related to the noncancer pain diagnosis and treatment.
Practitioners are confronted with the ethical and legal dilemma of being called to adequately treat chronic pain in a culture with a high prevalence of prescription drug abuse. Yet the symptoms of drug abuse are nonspecific and therefore of limited value to the practitioner in determining patient compliance to drug treatment regimens. In contrast, urine drug testing has a reliable history, both in and out of medicine, as an independent sign of drug misuse. This sign can be used to aid in the diagnosis and treatment of drug misuse and underlying addictions to improve patient outcomes.
Regular urine drug testing should be a part of acute and chronic pain management whether or not the patient has any signs or symptoms of drug misuse.</description><subject>Drug abuse</subject><subject>Drug testing</subject><subject>History, 20th Century</subject><subject>Humans</subject><subject>Kentucky</subject><subject>Legislation, Drug - trends</subject><subject>Medical diagnosis</subject><subject>Medicare - trends</subject><subject>Opioid-Related Disorders - diagnosis</subject><subject>Opioid-Related Disorders - prevention & control</subject><subject>Opioid-Related Disorders - urine</subject><subject>Pain</subject><subject>Pain, Intractable - drug therapy</subject><subject>Pain, Intractable - prevention & control</subject><subject>Practice Patterns, Physicians' - legislation & jurisprudence</subject><subject>Practice Patterns, Physicians' - standards</subject><subject>Practice Patterns, Physicians' - trends</subject><subject>Prescription drugs</subject><subject>Prescriptions - standards</subject><subject>Substance Abuse Detection - history</subject><subject>Substance Abuse Detection - legislation & jurisprudence</subject><subject>Substance Abuse Detection - standards</subject><subject>Substance abuse treatment</subject><subject>United States</subject><subject>Urinalysis - history</subject><subject>Urinalysis - standards</subject><subject>Urine</subject><issn>1533-3159</issn><issn>2150-1149</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkb1uHCEURpEVK9446V1FSClSjRe4AzOki6z8WLKUJqkRy9xZs96BCTDFPoFf20zspEiFxD3fJ7iHkCvOrkGxTm3n-XAtGGdbDluuujOyEVyyhvNWvyIbLgEa4FJfkDc5HxgDpTW8JheCAdPQw4Y83k5zTMUGhzSOdEk-IB3SsqcFc_FhT32g5R5pSWjLhKGsmLtPMXhHQwxujSY6Wx8-UT_NR-9s8THklUvo1sSEQ71NSOdYx6cat2GPea1-qPPFPZzekvPRHjO-ezkvya-vX37efG_ufny7vfl81zgQvDRDu3NaqI5bMVrZD4MV2ILsdsh7htZqHHk7Yjd2UqCVduhbLRX2445rpfoBLsnH5945xd9L_aKZfHZ4PNqAccmmA5AKFNeV_PAfeYhLCvVxRigp6yLbrq8Ue6ZcijknHM2c_GTTyXBm_jgy1ZFZHRkOpjqqkfcvxcuubuZf4K8UeAKCGI_q</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Gilbert, John W</creator><creator>Wheeler, G R</creator><creator>Mick, G E</creator><creator>Storey, B B</creator><creator>Herder, S L</creator><creator>Richardson, G B</creator><creator>Watts, E</creator><creator>Gyarteng-Dakwa, K</creator><creator>Marino, B S</creator><creator>Kenney, C M</creator><creator>Siddiqi, M</creator><creator>Broughton, P G</creator><general>American Society of Interventional Pain Physician</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky</title><author>Gilbert, John W ; Wheeler, G R ; Mick, G E ; Storey, B B ; Herder, S L ; Richardson, G B ; Watts, E ; Gyarteng-Dakwa, K ; Marino, B S ; Kenney, C M ; Siddiqi, M ; Broughton, P G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-d4bc92671a2fa58dda2e4357be180eaa9ef14fe7f752ea5ad84956e8fb19668d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Drug abuse</topic><topic>Drug testing</topic><topic>History, 20th Century</topic><topic>Humans</topic><topic>Kentucky</topic><topic>Legislation, Drug - trends</topic><topic>Medical diagnosis</topic><topic>Medicare - trends</topic><topic>Opioid-Related Disorders - diagnosis</topic><topic>Opioid-Related Disorders - prevention & control</topic><topic>Opioid-Related Disorders - urine</topic><topic>Pain</topic><topic>Pain, Intractable - drug therapy</topic><topic>Pain, Intractable - prevention & control</topic><topic>Practice Patterns, Physicians' - legislation & jurisprudence</topic><topic>Practice Patterns, Physicians' - standards</topic><topic>Practice Patterns, Physicians' - trends</topic><topic>Prescription drugs</topic><topic>Prescriptions - standards</topic><topic>Substance Abuse Detection - history</topic><topic>Substance Abuse Detection - legislation & jurisprudence</topic><topic>Substance Abuse Detection - standards</topic><topic>Substance abuse treatment</topic><topic>United States</topic><topic>Urinalysis - history</topic><topic>Urinalysis - standards</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gilbert, John W</creatorcontrib><creatorcontrib>Wheeler, G R</creatorcontrib><creatorcontrib>Mick, G E</creatorcontrib><creatorcontrib>Storey, B B</creatorcontrib><creatorcontrib>Herder, S L</creatorcontrib><creatorcontrib>Richardson, G B</creatorcontrib><creatorcontrib>Watts, E</creatorcontrib><creatorcontrib>Gyarteng-Dakwa, K</creatorcontrib><creatorcontrib>Marino, B S</creatorcontrib><creatorcontrib>Kenney, C M</creatorcontrib><creatorcontrib>Siddiqi, M</creatorcontrib><creatorcontrib>Broughton, P G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pain physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gilbert, John W</au><au>Wheeler, G R</au><au>Mick, G E</au><au>Storey, B B</au><au>Herder, S L</au><au>Richardson, G B</au><au>Watts, E</au><au>Gyarteng-Dakwa, K</au><au>Marino, B S</au><au>Kenney, C M</au><au>Siddiqi, M</au><au>Broughton, P G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky</atitle><jtitle>Pain physician</jtitle><addtitle>Pain Physician</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>13</volume><issue>2</issue><spage>167</spage><epage>186</epage><pages>167-186</pages><issn>1533-3159</issn><eissn>2150-1149</eissn><abstract>Urine drug testing has become a widely used tool in American society for deterring illicit drug use. In the practice of medicine, urine drug testing is commonly used to help diagnose substance misuse, abuse, or addiction.
This narrative review provides an informed perspective on the importance of urine drug testing in the medical treatment of chronic noncancer pain. The history and current uses of urine drug tests in the United States are reviewed, the prevalence and nature of prescription drug misuse is described as is related to chronic noncancer pain, and implications and considerations for practitioners are presented related to the noncancer pain diagnosis and treatment.
Practitioners are confronted with the ethical and legal dilemma of being called to adequately treat chronic pain in a culture with a high prevalence of prescription drug abuse. Yet the symptoms of drug abuse are nonspecific and therefore of limited value to the practitioner in determining patient compliance to drug treatment regimens. In contrast, urine drug testing has a reliable history, both in and out of medicine, as an independent sign of drug misuse. This sign can be used to aid in the diagnosis and treatment of drug misuse and underlying addictions to improve patient outcomes.
Regular urine drug testing should be a part of acute and chronic pain management whether or not the patient has any signs or symptoms of drug misuse.</abstract><cop>United States</cop><pub>American Society of Interventional Pain Physician</pub><pmid>20309383</pmid><doi>10.36076/ppj.2010/13/167</doi><tpages>20</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1533-3159 |
ispartof | Pain physician, 2010-03, Vol.13 (2), p.167-186 |
issn | 1533-3159 2150-1149 |
language | eng |
recordid | cdi_proquest_miscellaneous_733563619 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Drug abuse Drug testing History, 20th Century Humans Kentucky Legislation, Drug - trends Medical diagnosis Medicare - trends Opioid-Related Disorders - diagnosis Opioid-Related Disorders - prevention & control Opioid-Related Disorders - urine Pain Pain, Intractable - drug therapy Pain, Intractable - prevention & control Practice Patterns, Physicians' - legislation & jurisprudence Practice Patterns, Physicians' - standards Practice Patterns, Physicians' - trends Prescription drugs Prescriptions - standards Substance Abuse Detection - history Substance Abuse Detection - legislation & jurisprudence Substance Abuse Detection - standards Substance abuse treatment United States Urinalysis - history Urinalysis - standards Urine |
title | Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T15%3A03%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Importance%20of%20urine%20drug%20testing%20in%20the%20treatment%20of%20chronic%20noncancer%20pain:%20implications%20of%20recent%20medicare%20policy%20changes%20in%20kentucky&rft.jtitle=Pain%20physician&rft.au=Gilbert,%20John%20W&rft.date=2010-03-01&rft.volume=13&rft.issue=2&rft.spage=167&rft.epage=186&rft.pages=167-186&rft.issn=1533-3159&rft.eissn=2150-1149&rft_id=info:doi/10.36076/ppj.2010/13/167&rft_dat=%3Cproquest_cross%3E733563619%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2655993478&rft_id=info:pmid/20309383&rfr_iscdi=true |